Sunday, August 31, 2014
YOLO COUNTY NEWS
99 CENTS

UCD vets eye drug treatment for deadly horse disease

Alonso Guedes, an assistant professor of veterinary medicine, rescued Hulahalla, this 4-year-old thoroughbred mare, from the brink of death by administering an experimental anti-inflammatory drug to treat laminitis, an agonizingly painful foot disease. Don Preisler, UC Davis/Courtesy photo

By
From page A4 | November 23, 2012 |

UC Davis veterinarians have announced plans to conduct the first clinical trial of an experimental drug that has shown promise in treating horses stricken with laminitis, an excruciatingly painful and often life-threatening foot-related disease.

Four horses suffering from laminitis have been treated with the investigational anti-inflammatory drug so far. One experienced a complete remission that has lasted for more than a year, and three others have shown some improvement.

A paper on the first laminitis case has been accepted for publication by the peer-reviewed Journal of Veterinary Anaesthesia and Analgesia. The paper is expected to be published in the journal’s February issue, but journal editors authorized the authors to disclose their findings ahead of publication.

“This is an unusual step for us to announce this so far in advance, but because euthanasia is often the only way to alleviate pain in severe laminitis, we felt that it was important to let the veterinarians and horse owners know that this compound has shown potential as a treatment,” said Alonso Guedes, an assistant professor in the School of Veterinary Medicine.

The horses were treated under a “compassionate use” protocol approved by the UCD Institutional Animal Care and Use Committee. That protocol allows animals to be treated with an experimental drug if no approved alternative treatment exists.

A clinical trial to assess the drug’s safety and establish a tolerable dose for the compound is expected to begin in the spring. Further clinical trials would be needed to establish the drug’s effectiveness as a laminitis treatment.

The experimental compound, known as t-TUCB, belongs to a group of anti-inflammatory compounds called sEH (soluble epoxide hydrolases) inhibitors. It stems from a discovery made more than 40 years ago by entomology professor Bruce Hammock while doing basic insect biology research.

Originally interested in finding biological insect control methods, Hammock has since broadened his research to also search for biomedical applications. He and colleagues have identified a group of anti-inflammatory compounds, including the sEH inhibitors, that have proven to be effective in relieving inflammatory discomfort and pain related to nervous system disorders in mice and rats. Their work has been published in scientific journals including the Proceedings of the National Academy of Sciences and the Journal of Medicinal Chemistry.

Laminitis is a poorly understood condition involving inflammation of a horse’s nailbed — the connective tissue where the horse’s hoof and lower foot bone join. The inflammation is usually accompanied by swelling, a restriction of the blood supply to that area, high blood pressure, lameness and extreme pain.

Guedes noted that the safe management of laminitis-related pain is one of the biggest challenges for equine veterinarians. Often, euthanasia is the only humane alternative for alleviating pain and suffering in horses afflicted with the condition.

Consequently, the survival rate for laminitis is estimated to be only 25 percent. Very few surviving horses return to their previous levels of activity, and laminitis often reappears.

In his upcoming paper, Guedes reports the case of a 4-year old thoroughbred mare named Hulahalla that developed laminitis. The horse had been retired from racing following a tendon injury and donated to the UCD School of Veterinary Medicine, where it was participating in a study focused on healing tendon injuries using stem cell treatments.

Veterinarians from UCD’s William R. Pritchard Veterinary Medical Teaching Hospital treated the laminitis with conventional therapies including cold immersion, antibiotics, leg wraps, and two commonly used nonsteroidal drugs intended to reduce inflammation and relieve pain — but the horse only got worse. At the point that the mare was spending most of the day lying down, Guedes got involved.

Before resorting to euthanasia, Guedes and the veterinary team decided to try one last treatment, t-TUCB.

The veterinarians administered the experimental compound intravenously early on the eighth day of Hulahalla’s illness. After receiving the first dose, the horse remained standing in the stall most of the day, became interested in her surroundings and walked voluntarily.

The mare’s demeanor, posture and mobility continued to improve over four days of treatment, and her high blood pressure gradually returned to normal. No adverse affects from t-TUCB were observed, and Hulahalla has remained laminitis-free for a full year.

The sEH inhibitors, including t-TUCB, are currently available from the Hammock lab, which has provided the experimental compounds to more than 100 academic scientists around the world for basic investigation into their role in treating disease.

Hammock said that work aimed at moving t-TUCB and related compounds toward clinical use is advancing in several areas. He and Guedes are working on compounds with potential for targeting pain and arthritis in companion animals. And they are working with UCD to move the intellectual property from this research into a company to develop medications for difficult-to-manage neuropathic pain associated with diabetes and nerve injury.

Funding was provided by the National Institute of Environmental Health Sciences and the UCD Center for Equine Health.

— UC Davis News Service

Comments

comments

.

News

Davis audience hears from civil-rights hero

By Anne Ternus-Bellamy | From Page: A1 | Gallery

 
 
Legislators wrap up with water, ethics, guns bills

By The Associated Press | From Page: A2 | Gallery

 
Bob Dunning: This new kid might have a future

By Bob Dunning | From Page: A2

Five U.S. airstrikes target Islamic State fighters

By The Associated Press | From Page: A2

 
EU threatens Russia with more sanctions

By The Associated Press | From Page: A2

Robbery, pursuit in Central Davis lead to one arrest

By Anne Ternus-Bellamy | From Page: A3

 
Rotary clubs offer Davis High students some life lessons

By Evan Arnold-Gordon | From Page: A3 | Gallery

Yolo Federal to hold photo contest

By Enterprise staff | From Page: A4

 
Katehi will speak at Chamber’s community luncheon

By Enterprise staff | From Page: A4

Bean Feed supports for Yolo Democrats’ activities

By Enterprise staff | From Page: A4 | Gallery

 
Bauer garden marks one year

By Special to The Enterprise | From Page: A4

 
Dinner will raise funds to help farmers in Burkina Faso

By Enterprise staff | From Page: A4

Walkers welcome to join Sierra Club outings

By Enterprise staff | From Page: A4

 
Beamer Park featured at Stroll Through History

By Enterprise staff | From Page: A4

Tuleyome Tales: Be safe on wilderness trails

By Special to The Enterprise | From Page: A5 | Gallery

 
Small wineries suffer big losses in quake

By San Francisco Chronicle | From Page: A6 | Gallery

Grande site has been a convoluted saga

By Jeff Hudson | From Page: A7

 
Say goodbye to summer with a ‘Final Blast’ at Explorit

By Enterprise staff | From Page: A9 | Gallery

 
Bay Bridge project’s rainy-day money is nearly gone

By San Francisco Chronicle | From Page: A15 | Gallery

.

Forum

Already made herself at home

By Creators Syndicate | From Page: B5

 
How to make a good living

By Letters to the Editor | From Page: A10

Nate Beeler cartoon

By Debbie Davis | From Page: A10

 
Changing local election dates benefits Democrats

By Tom Elias | From Page: A10

Ad-free email? You can still find it at Davis Community Network

By Special to The Enterprise | From Page: A10

 
Keep our green waste piles

By Letters to the Editor | From Page: A10

Speak out

By Enterprise staff | From Page: A11

 
City panel working to tighten scrutiny of taxpayer dollars

By Special to The Enterprise | From Page: A11

Try round-robin storytelling at crafts fair

By Special to The Enterprise | From Page: A11

 
This epidemic should scare us

By Special to The Enterprise | From Page: A14

Health problems mean he’s checked out

By Creators Syndicate | From Page: A14

 
Marriage doesn’t mean we agree on everything

By Marion Franck | From Page: A14

.

Sports

Coach likes what she sees from Devil field hockey squad

By Enterprise staff | From Page: B1 | Gallery

 
UCD notebook: Coaches positive about FCS schools ‘playing up’

By Bruce Gallaudet | From Page: B1 | Gallery

Devils open with an impressive volleyball victory

By Spencer Ault | From Page: B1 | Gallery

 
Stanford scores early, often in opener versus UCD

By Bruce Gallaudet | From Page: B1 | Gallery

New coach, new tougher league for DHS football

By Thomas Oide | From Page: B1 | Gallery

 
Sports briefs: Aggie harriers secure season-opening sweep

By Enterprise staff | From Page: B2 | Gallery

Baseball roundup: Cats win late to pull even with Aces

By Staff and wire reports | From Page: B8

 
.

Features

.

Arts

.

Business

Comings and Goings: Is fro-yo craze melting?

By Wendy Weitzel | From Page: A13 | Gallery

 
Sutter Davis Hospital honored again as a ‘best place to work’

By Special to The Enterprise | From Page: A13

Engage3 attracts investment for shopping app

By Enterprise staff | From Page: A20

 
California growers can use MBI’s new bioinsecticide

By Special to The Enterprise | From Page: A20

Sudwerk, Davis Food Co-op join for ‘co-hop-eration’ brew

By Special to The Enterprise | From Page: A20 | Gallery

 
Community pools its purchasing power to reduce the cost of solar

By Special to The Enterprise | From Page: A20

.

Obituaries

Wanda P. Daley

By Special to The Enterprise | From Page: A4

 
.

Comics

Comics: Sunday, August 31, 2014

By Creator | From Page: B8